UiPath shares have had a tough start to the year, but the company has a big potential opportunity ahead.

UiPath stock has tumbled as optimism around its automation software has been overtaken by concern about artificial intelligence.

UiPath's focus on automating processes should put it in a great position to benefit from companies investing in artificial ...

UiPath (NYSE:PATH) declined approximately 6% in today’s session, trading below $12 midday on Thursday. The selloff is puzzling on the surface. UiPath just posted a quarter that beat expectations on ...

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath, Inc. (NYSE: PATH) to report Q4 earnings on March 11. Analysts expect EPS of $0.26 and revenue of $464.49 million.

UiPath PATH closed fiscal 2026 with a better-than-expected fiscal fourth quarter, a stronger profitability profile and ...

UiPath Inc PATH reported better-than-expected financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. The company reported revenue of $481.11 million versus ...

UiPath PATH, a key player in the robotic process automation (“RPA”) market, is trading at a forward 12-month price-to-sales (P/S) ratio of 4.12X, significantly below the industry average of 5.75X.

UiPath's RPA platform enables enterprises to automate workflows on a PC. Many legacy PC applications that businesses still rely on are difficult or impossible to integrate directly with other ...